BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3754288)

  • 1. Phagocyte function and immunological findings in a Wiskott-Aldrich syndrome long-term survivor.
    Capsoni F; Acerbi L; Bonora G; Perletti L; Ongari AM; Vanoli M; Zanussi C
    J Clin Lab Immunol; 1986 Feb; 19(2):91-7. PubMed ID: 3754288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of the Wiskott-Aldrich syndrome. From a new case report.
    Martín Mateos MA; Muñoz-López F; Cruz M
    Allergol Immunopathol (Madr); 1988; 16(2):113-9. PubMed ID: 3394592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorders of phagocyte function.
    Weston WL
    Arch Dermatol; 1976 Nov; 112(11):1589-96. PubMed ID: 984866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism.
    Blaese RM; Strober W; Levy AL; Waldmann TA
    J Clin Invest; 1971 Nov; 50(11):2331-8. PubMed ID: 5096517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute immune complex mediated glomerulonephritis in a Chinese girl with Wiskott-Aldrich syndrome variant.
    Lin CY; Hsu HC
    Ann Allergy; 1984 Jul; 53(1):74-8. PubMed ID: 6377982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome.
    Zabay JM; Fontán G; Campos A; García-Rodriguez MC; Pascual-Salcedo D; Bootello A; de la Concha EG
    Clin Exp Immunol; 1984 Apr; 56(1):23-8. PubMed ID: 6609033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in Wiskott-Aldrich syndrome: case report and literature review.
    Cheng DS; Cosgriff TM; Kitahara M
    Am J Med Sci; 1981; 282(2):85-90. PubMed ID: 7325190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired monocyte motility in sera from patients with systemic lupus erythematosus.
    Sturfelt G; Linder C; Sjöholm AG; Svensson B
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):151-8. PubMed ID: 6880748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non specific immunological response in moderate malnutrition.
    Carvalho Neves Forte W; Martins Campos JV; Carneiro Leao R
    Allergol Immunopathol (Madr); 1984; 12(6):489-96. PubMed ID: 6442096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of phagocytic functions in rheumatoid arthritis. II. Effects of serum factors on phagocytic and metabolic activities of neutrophils.
    Attia WM; Shams AH; Ali MK; Jang LW; Clark HW; Brown TM; Bellanti JA
    Ann Allergy; 1982 May; 48(5):283-7. PubMed ID: 7081781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of large granular lymphocyte subsets in Wiskott-Aldrich syndrome.
    Plebani A; Airò P; Brugnoni D; Lebowitz M; Cattaneo R; Monafo V; Meini A; Notarangelo LD; Duse M; Ugazio AG
    Haematologica; 1995; 80(6):521-5. PubMed ID: 8647517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WASp in immune-system organization and function.
    Thrasher AJ
    Nat Rev Immunol; 2002 Sep; 2(9):635-46. PubMed ID: 12209132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host defense in infantile osteopetrosis.
    Reeves JD; August CS; Humbert JR; Weston WL
    Pediatrics; 1979 Aug; 64(2):202-6. PubMed ID: 471611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
    Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory findings in a new case of leukocyte adhesion deficiency.
    Capsoni F; Soligo D; Minonzio F; Ongari AM; Polli N; Traversari K; Biolchini A; Timoncini G; Delia D
    Haematologica; 1990; 75(2):117-24. PubMed ID: 2358202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
    Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of IgG and complement receptor expression of phagocytes in kidney cancer patients during treatment with interferon-alpha.
    Salminen E; Kankuri M; Nuutila J; Lilius EM; Pellimiemi TT
    Anticancer Res; 2001; 21(3B):2049-55. PubMed ID: 11497297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.